About the Authors

Melissa K. Friswell

Affiliation Microbiology Research Group, School of Pharmacy and Pharmaceutical Sciences, The University of Manchester, Manchester, United Kingdom

Helen Gika

Affiliations AstraZeneca, Department of Clinical Pharmacology, Drug Metabolism and Pharmacokinetics, Macclesfield, United Kingdom, Department of Chemistry, Aristotle University of Thessaloniki, Thessaloniki, Greece

Ian J. Stratford

Affiliation Experimental Oncology Research Group, School of Pharmacy and Pharmaceutical Sciences, The University of Manchester, Manchester, United Kingdom

Georgios Theodoridis

Affiliations AstraZeneca, Department of Clinical Pharmacology, Drug Metabolism and Pharmacokinetics, Macclesfield, United Kingdom, Department of Chemistry, Aristotle University of Thessaloniki, Thessaloniki, Greece

Brian Telfer

Affiliation Experimental Oncology Research Group, School of Pharmacy and Pharmaceutical Sciences, The University of Manchester, Manchester, United Kingdom

Ian D. Wilson

Affiliation AstraZeneca, Department of Clinical Pharmacology, Drug Metabolism and Pharmacokinetics, Macclesfield, United Kingdom

Andrew J. McBain

andrew.mcbain@manchester.ac.uk

Affiliation Microbiology Research Group, School of Pharmacy and Pharmaceutical Sciences, The University of Manchester, Manchester, United Kingdom

Competing Interests

The authors have declared that no competing interests exist.

Author Contributions

Conceived and designed the experiments: MF IS IW AM. Performed the experiments: MF HG GT. Analyzed the data: MF AM. Contributed reagents/materials/analysis tools: IS BT IW AM. Wrote the paper: IW AM.